Saturday, October 20, 2018
Home U.S. Cannabis Stocks

U.S. Cannabis Stocks

High And Higher: The Money In Marijuana!

By Aswath Damodaran ByAswath Damodaran In 1992 when Bill Clinton was running for president of the United States and was asked whether he had...

Bristol-Myers Inks Deal and Invests $12 Million in Compugen

Bristol Myers Squibb Company BMY announced that it has entered a clinical trial collaboration with Compugen CGEN Per the deal the companies will evaluate...

2 Pharmaceutical Stocks to Buy With Dividends of 3% or Better

During a tough week for the overall market pharmaceutical stocks across the board fell a few notches despite a lack of significant news for...

5 of the Most Unique Marijuana Stocks

The sands of time are passing quickly In a mere two days adults in Canada will be free to legally purchase recreational cannabis in...

Company News For Oct 15, 2018

First Republic Bank FRC shares climbed 2 5 after the company reported third quarter 2018 revenues of 768 8 million beating the Zacks Consensus...

AbbVie Settles With Novartis to Delay Humira Biosimilar in US

AbbVie Inc ABBV announced that it has settled a litigation with Sandoz the generic arm of Novartis NVS involving AbbVie s blockbuster arthritis drug...

Pharma Stock Roundup: ABBV, NVS' Humira Biosimilar Agreement, BMY's New Cancer Deal

This week was a relatively quiet one for the pharma sector ahead of earnings In key developments AbbVie ABBV signed its fourth licensing deal...

Sandoz, AbbVie Announce Global Resolution Of Humira Patent Disputes

Sandoz, AbbVie Announce Global Resolution Of Humira Patent Disputes Source

3 Big Pharma Stocks Racing Along the Road to China

China has an immense cancer problem but it s about to get a lot better 160 The country s National Health Insurance Administration recently...

Here's Why Cara Therapeutics Rose 18.7% in September

What happened Shares of Cara Therapeutics NASDAQ CARA rose nearly 19 last month according to data provided by S amp P Global Market Intelligence...

LATEST POSTS